20th Annual Scientific Symposium Of The Cardiovascular Research Foundation: Oct. 12-17 In Washington, D.C.
Scientists at TCT 2008 - Transcatheter Cardiovascular Therapeutics - the global annual scientific symposium of the Cardiovascular Research Foundation - will present a variety of new data that promises to advance the field of interventional cardiology. Featured trials will focus on the safety and efficacy of new devices, including drug-eluting stents and other leading edge technologies, as well as comparisons of minimally invasive therapies to either medical treatment or surgery.
The following late breaking trials will be reported:
* HORIZONS-AMI: A Prospective Randomized Trial of... Paclitaxel-Eluting Stents vs. Bare-Metal Stents in Patients with Acute ST-Segment Elevation Myocardial Infarction
* HORIZONS-AMI: A Prospective Randomized Trial of Bivalirudin vs. Unfractionated Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Acute ST-Segment Elevation Myocardial Infarction: Long-Term Follow-Up and Interaction with Stent Type
* SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease
* ISAR-Left Main: A Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents in Unprotected Left Main Coronary Artery Disease
* FAME: A Prospective Randomized Trial of Fractional Flow Reserve Guided Stenting in Patients with Multivessel Coronary Artery Disease
* ZEST-AMI: A Prospective Randomized Comparison of Zotarolimus-Eluting Stents, Sirolimus-Eluting Stents, and Paclitaxel-Eluting Stents in Patients with Acute Myocardial Infarction
* PREPARE: A Prospective Randomized Trial of Proximal Microcirculatory Protection in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
* BBC ONE: A Prospective Randomized Comparison of a Single Drug-Eluting Stent Provisional Strategy vs. Routine Dual Drug-Eluting Stents for Coronary Bifurcation Lesions
* ISAR-TEST-2: A Prospective Randomized Trial Comparing Polymer-Free Rapamycin-Eluting and Probucol-Eluting Stents, Polymer-Based Sirolimus-Eluting Stents, and Zotarolimus-Eluting Stents in Patients with Coronary Artery Disease
Click here to see the complete list of late breaking clinical trials and first report randomized trials and registries.
In addition, research presented at TCT will showcase breaking data in other areas of interventional cardiology:
* Drug therapies that may reduce plaque
* The differences in the ways that men and women with similar symptoms are treated by physicians
* New types of stents, including bioabsorbable devices
* New ways of detecting and reducing plaque, including vulnerable plaque that can cause sudden heart attack and death
WHEN:
October 12-17, 2008; Late-breaking clinical trials will be highlighted during press conferences scheduled on Tuesday, October 14, Wednesday, October 15, and Thursday, October 16.
WHERE:
Walter E. Washington Convention Center; Washington, DC
----------------------------
Article adapted by Medical News Today from original press release.
----------------------------
The following late breaking trials will be reported:
* HORIZONS-AMI: A Prospective Randomized Trial of... Paclitaxel-Eluting Stents vs. Bare-Metal Stents in Patients with Acute ST-Segment Elevation Myocardial Infarction
* HORIZONS-AMI: A Prospective Randomized Trial of Bivalirudin vs. Unfractionated Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Acute ST-Segment Elevation Myocardial Infarction: Long-Term Follow-Up and Interaction with Stent Type
* SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease
* ISAR-Left Main: A Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents in Unprotected Left Main Coronary Artery Disease
* FAME: A Prospective Randomized Trial of Fractional Flow Reserve Guided Stenting in Patients with Multivessel Coronary Artery Disease
* ZEST-AMI: A Prospective Randomized Comparison of Zotarolimus-Eluting Stents, Sirolimus-Eluting Stents, and Paclitaxel-Eluting Stents in Patients with Acute Myocardial Infarction
* PREPARE: A Prospective Randomized Trial of Proximal Microcirculatory Protection in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
* BBC ONE: A Prospective Randomized Comparison of a Single Drug-Eluting Stent Provisional Strategy vs. Routine Dual Drug-Eluting Stents for Coronary Bifurcation Lesions
* ISAR-TEST-2: A Prospective Randomized Trial Comparing Polymer-Free Rapamycin-Eluting and Probucol-Eluting Stents, Polymer-Based Sirolimus-Eluting Stents, and Zotarolimus-Eluting Stents in Patients with Coronary Artery Disease
Click here to see the complete list of late breaking clinical trials and first report randomized trials and registries.
In addition, research presented at TCT will showcase breaking data in other areas of interventional cardiology:
* Drug therapies that may reduce plaque
* The differences in the ways that men and women with similar symptoms are treated by physicians
* New types of stents, including bioabsorbable devices
* New ways of detecting and reducing plaque, including vulnerable plaque that can cause sudden heart attack and death
WHEN:
October 12-17, 2008; Late-breaking clinical trials will be highlighted during press conferences scheduled on Tuesday, October 14, Wednesday, October 15, and Thursday, October 16.
WHERE:
Walter E. Washington Convention Center; Washington, DC
----------------------------
Article adapted by Medical News Today from original press release.
----------------------------